BPC-157 Research Peptide

BPC-157 is the common name for a synthetic 15-amino-acid peptide also described as a gastric pentadecapeptide.

• BPC-157, BPC157, and BPC 157 are spelling variants; “body protection compound” is a name, not evidence of a protective clinical effect.

The compound is a short synthetic peptide investigated mainly in experimental models.

• Sequence confirmation and mass analysis are needed to identify a sample because a label or reported purity percentage is not sufficient.

Studies have explored gastrointestinal protection, angiogenesis, nitric-oxide-related signaling, inflammation, and tissue-repair pathways.

• The proposed mechanisms remain incompletely defined, and findings from one injury model cannot be generalized to other tissues or to people.

The literature is dominated by cell and animal studies involving gastrointestinal, muscle, tendon, ligament, nerve, and wound models.

• Systematic reviews identify extensive preclinical reporting but very limited and weakly controlled human evidence.

BPC-157 is not an FDA-approved medicine, and it is prohibited in sport under current World Anti-Doping Agency rules.

• No standardized general clinical formulation or validated regimen has been established; unregulated material also raises unresolved identity, contamination, and sterility questions.